Reference is made to the stock exchange notice published by Hofseth BioCare ASA ("Hofseth BioCare") on 27 June 2013 concerning the issue of 7,048,734 shares, each with a par value of NOK 1.00, at a subscription price of NOK 3.20 per share pursuant to an authorization from the general meeting to the board as of 22 March 2013.
The share capital increase related to the private placement resolved by the board meeting held 27 June 2013 according to authorization from the general meeting of Hofseth BioCare has now been registered with the Norwegian Register of Business Enterprises.
The share capital of Hofseth BioCare is NOK 77,536,088 divided into 77,536,088 shares, each with a nominal value of NOK 1.
For further information, please contact:
Jon Olav Ødegård, CEO Hofseth BioCare ASA
Tel +47 936 32 966
E-mail: joo@h-bc.no
Øystein Omvik, CFO Hofseth BioCare ASA
Tel: +47 936 99 400
E-mail: oystein.omvik@h-bc.no
About Hofseth BioCare:
Hofseth BioCare is a Norwegian biomarine company with the key objective to provide high value added biomarine ingredients for human applications. The Company is founded on the core value of sustainability and optimal use of natural resources. Through innovative production technology and logistics, Hofseth BioCare is able to preserve the quality of protein, calcium and oil extracted from fish off-cuts.
Products that previously could only be used as animal feed can now be made suitable for human consumption. HBCs objective is thus to contribute to efficient use of marine resources and entering the higher profit market of quality ingredients for human applications.